Federica Marchiotto

Federica Marchiotto

Auto-generated profile, based on publicly available information

Federica Marchiotto

Dept. of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Neurochemistry International
Verified
Journal Article
Closed access
MPMatteo Pedrazzoli
Matteo Pedrazzoli
MMManuela Medelin
Manuela Medelin
FMFederica Marchiotto
Federica Marchiotto
Barbara CisternaBarbara Cisterna
Barbara Cisterna
Manuela MalatestaManuela Malatesta
Manuela Malatesta
MBMario Buffelli
Mario Buffelli

8 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MBMartino Bonato
Martino Bonato
FMFederica Marchiotto
Federica Marchiotto
MAMaryam Khastkhodaei Ardakani
Maryam Khastkhodaei Ardakani
FFFederico G. P. Ferrari
Federico G. P. Ferrari
NCNiccolò Di Cintio
Niccolò Di Cintio
EBEnrica Boda
Enrica Boda
Neurodevelopmental disorders (NDDs) are increasingly recognized as disorders of brain connectivity and circuit dysfunction. Growing evidence suggests that glial cell and myelin abnormalities may actively contribute to these alterations. Yet, they have been often considered secondary consequences of impaired neuronal development rather than primary drivers of circuit dysfunction. Primary autosomal recessive microcephaly type 17 (MCPH17) is a severe NDD caused by mutations in the CIT gene, encoding Citron kinase (CIT-K). The disease is associated with cognitive and motor deficits, epilepsy susceptibility, and marked hypomyelination in both patients and mouse models, suggesting a contribution of oligodendroglial dysfunction to disease pathophysiology. Here, we investigated the specific role of oligodendroglial Cit-k loss using Sox10 Cre ;Cit-k fl/fl mice, in which Cit-k is selectively deleted in oligodendrocyte-lineage cells. Mutant mice displayed impaired forebrain myelination at juvenile stages and persistent cortical hypomyelination in adulthood. Despite preserved gross motor function, adult mutants showed deficits in fine motor control, working and recognition memory, and auditory fear memory. These impairments were associated with altered cortico-cortical and cortico-hippocampal functional connectivity. Moreover, consistent with the clinical MCPH17 phenotype, mutant mice exhibited increased susceptibility to kainate-induced seizures. Together, our findings show that oligodendroglial Cit-k loss and the resulting hypomyelination are sufficient to produce long-lasting neurological and behavioral impairments independently of primary neuronal defects. These results identify oligodendrocytes as active contributors to MCPH17 and support a broader role for myelin abnormalities in NDDs. Highlights: Cit-k deletion in oligodendroglia disrupts forebrain myelination Cortical hypomyelination persists in adult mutant mice Mutant mice show deficits in motor control and memory Cortico-cortical and cortico-hippocampal connectivity are altered ligodendrocytes contribute to microcephaly-associated dysfunctions

23 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
EBEnrica Boda
Enrica Boda
FMFederica Marchiotto
Federica Marchiotto
APAlessandro Pigozzi
Alessandro Pigozzi
ANNALISA BUFFOANNALISA BUFFO
ANNALISA BUFFO
MBMario Buffelli
Mario Buffelli
Marco CambiaghiMarco Cambiaghi
Marco Cambiaghi
Cortical myelin loss and oligodendroglial dysfunction, hallmarks of numerous neurodegenerative and psychiatric disorders, compromise executive, sensory, and cognitive functions by altering circuit activity and integrity. Promoting cortical myelin repair therefore represents a critical therapeutic goal. In this frame, modulation of neuronal activity through non-invasive brain stimulation may represent a promising non-pharmacological approach to support remyelination. To address this issue, we investigated the effects of anodal transcranial direct current stimulation (A-tDCS) in a mouse model of unilateral myelin injury in the motor cortex. A-tDCS was delivered over the contralateral uninjured cortex during a bilateral motor task (locomotion), to enhance the physiological activity of interhemispheric M1–M1 projections and indirectly stimulate the lesioned cortex. When applied during the late phase of demyelination and the onset of repair, A-tDCS accelerated remyelination and increased oligodendroglial survival and maturation in the lesioned cortex, compared with unstimulated controls. Increased myelin was also detected in the directly stimulated uninjured cortex despite unchanged oligodendroglial cell numbers, suggesting de novo myelin formation or remodeling of existing internodes. These structural changes were accompanied by preservation of interhemispheric M1–M1 functional connectivity upon injury. Collectively, our findings demonstrate that A-tDCS promotes cortical myelin repair in vivo , supporting its therapeutic potential for disorders characterized by myelin damage. Notably, the observed effects of tDCS on myelin plasticity in the uninjured cortex – reported here for the first time - reveal a previously unrecognized mechanism underlying tDCS-mediated neuromodulation. Highlights: Anodal tDCS (A-tDCS) promotes remyelination in the mouse motor cortex (M1) and restores M1–M1 synchrony after demyelinating injury A-tDCS enhances oligodendroglial survival and maturation in the injured motor cortex A-tDCS induces myelin plasticity in the uninjured cortex